Cargando…
The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage Disease
Autores principales: | Monaco, Antonio, Maffia, Veronica, Sorrentino, Nicolina Cristina, Sambri, Irene, Ezhova, Yulia, Giuliano, Teresa, Cacace, Vincenzo, Nusco, Edoardo, De Risi, Maria, De Leonibus, Elvira, Schrader, Thomas, Klärner, Frank-Gerrit, Bitan, Gal, Fraldi, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637752/ https://www.ncbi.nlm.nih.gov/pubmed/36261045 http://dx.doi.org/10.1016/j.ymthe.2022.10.001 |
Ejemplares similares
-
The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage Disease
por: Monaco, Antonio, et al.
Publicado: (2020) -
Amyloid β-Protein Assembly: The Effect
of Molecular Tweezers CLR01 and CLR03
por: Zheng, Xueyun, et al.
Publicado: (2015) -
Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases
por: Sambri, Irene, et al.
Publicado: (2016) -
Safety and pharmacological characterization of the molecular tweezer CLR01 – a broad-spectrum inhibitor of amyloid proteins’ toxicity
por: Attar, Aida, et al.
Publicado: (2014) -
CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
por: Bengoa-Vergniory, Nora, et al.
Publicado: (2020)